Front Page - Latvijas Organiskās sintēzes institūts

Menu

The leading drug discovery and development centre in the Baltics

Latvian Institute of Organic Synthesis opens Biotechnology facility

LIOS and TBD Pharmatech join forces to increase the drug manufacturing performance

The Prime Minister of Latvia visited the Latvian Institute of Organic Synthesis

LIOS is a Consortium Partner in a New EU-funded Project: Fragment-Screen

LIOS launches ERA Chair project NATALION funded by European Union

Researchers at LIOS find a simple and convenient method for the synthesis of monofluoromethyl containing molecules

Latvian Institute of Organic Synthesis (LIOS) receives €2.5 M ERA Chair grant from Horizon Europe Framework Programme

An attractive methodology for obtaining 1-aminoisoquinoline derivatives

Research

Services

Laboratories

Research in organic chemistry, pharmaceutical research, molecular biology and bioorganic chemistry

News

Latvian Institute of Organic Synthesis opens Biotechnology facility

29/03/2023

On March 29, 2023, the Latvian Institute of Organic Synthesis...

LIOS and TBD Pharmatech join forces to increase the drug manufacturing performance

27/02/2023

On 21st February 2023, the Latvian Institute of Organic Synthesis...

Call for Abstracts

21/02/2023

The Scientific Committee of the Congress has developed a two-day...

The Prime Minister of Latvia visited the Latvian Institute of Organic Synthesis

17/02/2023

On February 16th (2023), the Latvian Institute of Organic Synthesis...

LIOS is a Consortium Partner in a New EU-funded Project: Fragment-Screen

03/02/2023

The new Fragment-Screen project is born from the INFRA-2022-TECH-01 call...